DFSVX
Price
$48.18
Change
-$1.97 (-3.93%)
Updated
Dec 18 closing price
ROFRX
Price
$13.28
Change
-$0.52 (-3.77%)
Updated
Dec 18 closing price
Ad is loading...

DFSVX vs ROFRX

Header iconDFSVX vs ROFRX Comparison
Open Charts DFSVX vs ROFRXBanner chart's image
DFA US Small Cap Value I
Price$48.18
Change-$1.97 (-3.93%)
VolumeN/A
CapitalizationN/A
Royce Small-Cap Opportunity R
Price$13.28
Change-$0.52 (-3.77%)
VolumeN/A
CapitalizationN/A
DFSVX vs ROFRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFSVX vs. ROFRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a Buy and ROFRX is a Hold.

FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 16.9B vs. ROFRX (1.22B). DFSVX pays higher dividends than ROFRX: DFSVX (1.44) vs ROFRX (0.00). DFSVX was incepted earlier than ROFRX: DFSVX (32 years) vs ROFRX (18 years). ROFRX is a more actively managed with annual turnover of: 35.00 vs. DFSVX (25.00). DFSVX has a lower initial minimum investment than ROFRX: DFSVX (0) vs ROFRX (1000). DFSVX annual gain was more profitable for investors over the last year : 15.68 vs. ROFRX (7.73). DFSVX return over 5 years is better than : 52.30 vs. ROFRX (24.21).
DFSVXROFRXDFSVX / ROFRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years18 years-
Gain YTD13.2834.704282%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.9B1.22B1,391%
Annual Yield % from dividends1.440.00-
Returns for 1 year15.687.73203%
Returns for 3 years24.57-2.27-1,084%
Returns for 5 years52.3024.21216%
Returns for 10 years52.9111.74451%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VXRT0.590.01
+0.99%
Vaxart
DVA147.57-3.02
-2.01%
DaVita
PINC21.17-0.59
-2.71%
Premier
LXU8.25-0.41
-4.73%
LSB Industries
SYRS0.21-0.01
-4.91%
Syros Pharmaceuticals